Trial
NCT00532311
Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Takeda
Collaborators
—
Condition
Hypercholesterolemia
Intervention
Lapaquistat acetate and stable statin therapy
Why stopped
Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-22